1. Home
  2. Clinical Topics
  3. FDA approves drug for sexual desires disorders in women
Clinical TopicsDrugs and DevicesNewsWeb ExclusivesWomen's Health

FDA approves drug for sexual desires disorders in women

Share

On Aug. 18, the U.S. Food and Drug Administration (FDA) approved Addyi (flibanserin) to treat acquired, generalized hypoactive sexual desire disorder in premenopausal women. Read more

Leave a Reply

Your email address will not be published.

Fill out this field
Fill out this field
Please enter a valid email address.

Get your free subscription to NurseLine!

NurseLine Newsletter

  • Hidden

*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.

Recent Posts